US health chiefs urge caution on experimental Ebola interventions
This article was originally published in SRA
With the situation regarding the Ebola virus disease epidemic growing more desperate with each passing day, a vaccine to get the virus under control is urgently needed, as are effective and safe drugs to treat patients with the deadly disease, two top US health officials said. They warned, however, that there must be a balance with the urgent desire to deploy experimental countermeasures for diseases such as Ebola with the need to ensure safety and determine the efficacy of the products.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.